CHB

Global X China Biotech Innovation ETF
*Unless otherwise stated, data provided by FactSet.

CHB Fund Description

CHB tracks a market-cap weighted index of Chinese companies that are involved in the biotechnology industry.

CHB Factset Analytics Insight

CHB is passively managed to provide exposure to a narrow basket of Chinese biotechnology stocks. Companies must be headquartered in China or Hong Kong and directly involved in the biotechnology industry as defined by FactSet. Stocks may be of any capitalization size. However, shares must be listed on a major exchange and include H-shares, red-chips, P-chips, and A-shares which are subject to daily quota limits. Stocks selected for the index are market-cap weighted and subject to 8% cap. Companies that weight 5% or more are capped in at 40% in aggregate weight of the total. The index follows a semi-annual rebalance schedule on the second Friday in May and November.

CHB MSCI ESG Analytics Insight

Global X China Biotech Innovation ETF has an MSCI ESG Fund Rating of B based on a score of 1.60 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. Global X China Biotech Innovation ETF ranks in the 1st percentile within its peer group and in the 3th percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.

CHB MSCI FaCS and Factor Box

MSCI FaCS is a standard method for evaluating and reporting the Factor characteristics of equity portfolios including ETFs. The Factor Box includes 6 Factors that MSCI has identified that historically provided a return premium. On the vertical axis, the Factor Groups, are displayed and the horizontal axis displays the Factor exposure, overweight, underweight or neutral.

PERFORMANCE [as of 09/22/21] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
CHB 0.61% -11.14% -0.01% -- -- -- --
CHB (NAV) 2.11% -10.25% 0.86% -- -- -- --
N/A -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

CHB Summary Data

Global X
09/22/20
Open-Ended Fund
0.67%
$5.15M
$36.44K
0.81%

CHB Portfolio Data

$17.75B
155.01
7.27
--
12/30/21
35

CHB Index Data

Solactive China Biotech Innovation Index
Market Cap
Market Cap
N/A

CHB Portfolio Management

0.67%
--
--
--

CHB Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

CHB Fund Structure

Open-Ended Fund
No
Yes
-- / --
N/A
N/A
High
Daily

CHB Factset Analytics Block Liquidity

As of 09/23/21
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of CHB. CHB is rated a 4 out of 5.

CHB Tradability

2,115
$36.44K
1,134
$19.26K
0.81%
$0.14
0.54%
2.35% / -2.72%
None
13.00%
50,000
0.02
0.07%
0.05%
0
$16.47
4

CHB Sector/Industry Breakdown


CHB
Segment Benchmark
34.48%
--
17.04%
--
13.27%
--
6.74%
--
5.88%
--
4.26%
--
2.70%
--
1.99%
--
0.65%
--
0.59%
--

CHB Top 10 Holdings[View All]

10.34%
10.25%
5.95%
4.38%
4.33%
4.24%
4.22%
3.88%
3.78%
61.68%

CHB Countries


CHB
Segment Benchmark
62.69%
--
37.31%
--

CHB Regions


CHB
Segment Benchmark
100.00%
--

CHB Economic Development


CHB
Segment Benchmark
62.69%
--
37.31%
--

CHB Performance Statistics

--
--
--
--
0.00%
N/A

CHB MSCI ESG Ratings

1.60 / 10
3.20
0.78
--
10.96%
47.86

CHB Benchmark Comparison Holdings

35
--
--
0.00%

CHB Benchmark Comparison Summary


CHB
Segment Benchmark
35
--
$17.75B
--
155.01
--
7.27
--
0.31%
--
High
High

CHB Benchmark Comparison Market Cap Size


CHB
Segment Benchmark
51.78%
--
40.04%
--
8.18%
--
0.00%
--